KR20210125273A - Health functional food for adult men and Manufacturing method thereof - Google Patents
Health functional food for adult men and Manufacturing method thereof Download PDFInfo
- Publication number
- KR20210125273A KR20210125273A KR1020200042781A KR20200042781A KR20210125273A KR 20210125273 A KR20210125273 A KR 20210125273A KR 1020200042781 A KR1020200042781 A KR 1020200042781A KR 20200042781 A KR20200042781 A KR 20200042781A KR 20210125273 A KR20210125273 A KR 20210125273A
- Authority
- KR
- South Korea
- Prior art keywords
- red ginseng
- maca
- health
- adult men
- fermented red
- Prior art date
Links
- 230000036541 health Effects 0.000 title claims abstract description 19
- 235000013376 functional food Nutrition 0.000 title claims description 14
- 238000004519 manufacturing process Methods 0.000 title abstract description 13
- 235000002789 Panax ginseng Nutrition 0.000 claims abstract description 83
- 240000000759 Lepidium meyenii Species 0.000 claims abstract description 24
- 235000000421 Lepidium meyenii Nutrition 0.000 claims abstract description 24
- 240000006661 Serenoa repens Species 0.000 claims abstract description 24
- 235000012902 lepidium meyenii Nutrition 0.000 claims abstract description 24
- 235000005318 Serenoa repens Nutrition 0.000 claims abstract description 22
- 239000010018 saw palmetto extract Substances 0.000 claims abstract description 22
- 235000015872 dietary supplement Nutrition 0.000 claims abstract description 8
- 230000006870 function Effects 0.000 abstract description 14
- 230000000694 effects Effects 0.000 abstract description 10
- 230000005764 inhibitory process Effects 0.000 abstract description 8
- 230000017531 blood circulation Effects 0.000 abstract description 7
- 235000013305 food Nutrition 0.000 abstract description 7
- 230000019100 sperm motility Effects 0.000 abstract description 7
- 239000003963 antioxidant agent Substances 0.000 abstract description 6
- 230000003078 antioxidant effect Effects 0.000 abstract description 6
- 230000036039 immunity Effects 0.000 abstract description 6
- 239000000463 material Substances 0.000 abstract description 6
- 230000015654 memory Effects 0.000 abstract description 6
- 238000000034 method Methods 0.000 abstract description 6
- 208000010110 spontaneous platelet aggregation Diseases 0.000 abstract description 6
- 230000037209 prostate health Effects 0.000 abstract description 4
- 239000000796 flavoring agent Substances 0.000 abstract description 2
- 235000019634 flavors Nutrition 0.000 abstract description 2
- 239000002075 main ingredient Substances 0.000 abstract 1
- 235000016709 nutrition Nutrition 0.000 abstract 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 34
- 241000894006 Bacteria Species 0.000 description 17
- 239000004310 lactic acid Substances 0.000 description 17
- 235000014655 lactic acid Nutrition 0.000 description 17
- 239000000203 mixture Substances 0.000 description 12
- 241000186660 Lactobacillus Species 0.000 description 11
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 10
- 229940039696 lactobacillus Drugs 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 9
- 239000000284 extract Substances 0.000 description 9
- 238000001914 filtration Methods 0.000 description 9
- 230000006872 improvement Effects 0.000 description 9
- UFNDONGOJKNAES-UHFFFAOYSA-N Ginsenoside Rb1 Natural products CC(=CCCC(C)(OC1OC(COC2OC(CO)C(O)C(O)C2O)C(O)C(O)C1O)C3CCC4(C)C3C(O)CC5C6(C)CCC(OC7OC(CO)C(O)C(O)C7OC8OC(CO)C(O)C(O)C8O)C(C)(C)C6CC(O)C45C)C UFNDONGOJKNAES-UHFFFAOYSA-N 0.000 description 8
- YURJSTAIMNSZAE-UHFFFAOYSA-N UNPD89172 Natural products C1CC(C2(CC(C3C(C)(C)C(O)CCC3(C)C2CC2O)OC3C(C(O)C(O)C(CO)O3)O)C)(C)C2C1C(C)(CCC=C(C)C)OC1OC(CO)C(O)C(O)C1O YURJSTAIMNSZAE-UHFFFAOYSA-N 0.000 description 8
- GZYPWOGIYAIIPV-JBDTYSNRSA-N ginsenoside Rb1 Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)O[C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(CC[C@H]4C(C)(C)[C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O)CC[C@]4(C)[C@H]3C[C@H]2O)C)(C)CC1)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O GZYPWOGIYAIIPV-JBDTYSNRSA-N 0.000 description 8
- TXEWRVNOAJOINC-UHFFFAOYSA-N ginsenoside Rb2 Natural products CC(=CCCC(OC1OC(COC2OCC(O)C(O)C2O)C(O)C(O)C1O)C3CCC4(C)C3C(O)CC5C6(C)CCC(OC7OC(CO)C(O)C(O)C7OC8OC(CO)C(O)C(O)C8O)C(C)(C)C6CCC45C)C TXEWRVNOAJOINC-UHFFFAOYSA-N 0.000 description 8
- YURJSTAIMNSZAE-HHNZYBFYSA-N ginsenoside Rg1 Chemical compound O([C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(C[C@@H]([C@H]4C(C)(C)[C@@H](O)CC[C@]4(C)[C@H]3C[C@H]2O)O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)C)(C)CC1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O YURJSTAIMNSZAE-HHNZYBFYSA-N 0.000 description 8
- CBEHEBUBNAGGKC-UHFFFAOYSA-N ginsenoside Rg1 Natural products CC(=CCCC(C)(OC1OC(CO)C(O)C(O)C1O)C2CCC3(C)C2C(O)CC4C5(C)CCC(O)C(C)(C)C5CC(OC6OC(CO)C(O)C(O)C6O)C34C)C CBEHEBUBNAGGKC-UHFFFAOYSA-N 0.000 description 8
- 239000007788 liquid Substances 0.000 description 8
- 239000000843 powder Substances 0.000 description 8
- 239000008213 purified water Substances 0.000 description 8
- 230000001850 reproductive effect Effects 0.000 description 7
- RWXIFXNRCLMQCD-JBVRGBGGSA-N (20S)-ginsenoside Rg3 Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H]1CC[C@]2(C)[C@H]3C[C@@H](O)[C@H]4[C@@]([C@@]3(CC[C@H]2C1(C)C)C)(C)CC[C@@H]4[C@@](C)(O)CCC=C(C)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O RWXIFXNRCLMQCD-JBVRGBGGSA-N 0.000 description 6
- XIRZPICFRDZXPF-UHFFFAOYSA-N Ginsenoside Rg3 Natural products CC(C)=CCCC(C)(O)C1CCC(C2(CC(O)C3C4(C)C)C)(C)C1C(O)CC2C3(C)CCC4OC1OC(CO)C(O)C(O)C1OC1OC(CO)C(O)C(O)C1O XIRZPICFRDZXPF-UHFFFAOYSA-N 0.000 description 6
- 239000012141 concentrate Substances 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 235000006708 antioxidants Nutrition 0.000 description 5
- 229960003604 testosterone Drugs 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 241000186000 Bifidobacterium Species 0.000 description 4
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 4
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 238000000855 fermentation Methods 0.000 description 4
- 230000004151 fermentation Effects 0.000 description 4
- 230000009245 menopause Effects 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 235000019629 palatability Nutrition 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 241000192132 Leuconostoc Species 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 235000015165 citric acid Nutrition 0.000 description 3
- 235000003599 food sweetener Nutrition 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 235000010755 mineral Nutrition 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 210000000582 semen Anatomy 0.000 description 3
- 239000003765 sweetening agent Substances 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 description 2
- 239000004475 Arginine Substances 0.000 description 2
- 241001608472 Bifidobacterium longum Species 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- 229920001353 Dextrin Polymers 0.000 description 2
- 239000004375 Dextrin Substances 0.000 description 2
- 241000194033 Enterococcus Species 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 240000002605 Lactobacillus helveticus Species 0.000 description 2
- 235000013967 Lactobacillus helveticus Nutrition 0.000 description 2
- 240000006024 Lactobacillus plantarum Species 0.000 description 2
- 235000013965 Lactobacillus plantarum Nutrition 0.000 description 2
- 206010027304 Menopausal symptoms Diseases 0.000 description 2
- 229920000881 Modified starch Polymers 0.000 description 2
- 239000004368 Modified starch Substances 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 244000228451 Stevia rebaudiana Species 0.000 description 2
- 241000194017 Streptococcus Species 0.000 description 2
- 244000057717 Streptococcus lactis Species 0.000 description 2
- 235000014897 Streptococcus lactis Nutrition 0.000 description 2
- 241000194020 Streptococcus thermophilus Species 0.000 description 2
- 239000004376 Sucralose Substances 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 239000000619 acesulfame-K Substances 0.000 description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 2
- 229940009291 bifidobacterium longum Drugs 0.000 description 2
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- 229960002079 calcium pantothenate Drugs 0.000 description 2
- 235000019425 dextrin Nutrition 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 210000004392 genitalia Anatomy 0.000 description 2
- 229940089161 ginsenoside Drugs 0.000 description 2
- 229930182494 ginsenoside Natural products 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229940054346 lactobacillus helveticus Drugs 0.000 description 2
- 229940072205 lactobacillus plantarum Drugs 0.000 description 2
- 239000000845 maltitol Substances 0.000 description 2
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 2
- 235000010449 maltitol Nutrition 0.000 description 2
- 229940035436 maltitol Drugs 0.000 description 2
- 235000019426 modified starch Nutrition 0.000 description 2
- 235000005152 nicotinamide Nutrition 0.000 description 2
- 239000011570 nicotinamide Substances 0.000 description 2
- CNNRPFQICPFDPO-UHFFFAOYSA-N octacosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCO CNNRPFQICPFDPO-UHFFFAOYSA-N 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 description 2
- 235000019408 sucralose Nutrition 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 239000011787 zinc oxide Substances 0.000 description 2
- 229960002666 1-octacosanol Drugs 0.000 description 1
- 241001489705 Aquarius Species 0.000 description 1
- 240000006914 Aspalathus linearis Species 0.000 description 1
- 206010004446 Benign prostatic hyperplasia Diseases 0.000 description 1
- 241000186016 Bifidobacterium bifidum Species 0.000 description 1
- 241000186015 Bifidobacterium longum subsp. infantis Species 0.000 description 1
- 108010066551 Cholestenone 5 alpha-Reductase Proteins 0.000 description 1
- 241000194032 Enterococcus faecalis Species 0.000 description 1
- 241000194031 Enterococcus faecium Species 0.000 description 1
- 102000012673 Follicle Stimulating Hormone Human genes 0.000 description 1
- 108010079345 Follicle Stimulating Hormone Proteins 0.000 description 1
- 239000009429 Ginkgo biloba extract Substances 0.000 description 1
- 240000001046 Lactobacillus acidophilus Species 0.000 description 1
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 description 1
- 241000186715 Lactobacillus alimentarius Species 0.000 description 1
- 244000199885 Lactobacillus bulgaricus Species 0.000 description 1
- 235000013960 Lactobacillus bulgaricus Nutrition 0.000 description 1
- 244000199866 Lactobacillus casei Species 0.000 description 1
- 235000013958 Lactobacillus casei Nutrition 0.000 description 1
- 241000186673 Lactobacillus delbrueckii Species 0.000 description 1
- 241000186840 Lactobacillus fermentum Species 0.000 description 1
- 241000186606 Lactobacillus gasseri Species 0.000 description 1
- 241000186612 Lactobacillus sakei Species 0.000 description 1
- 102000009151 Luteinizing Hormone Human genes 0.000 description 1
- 108010073521 Luteinizing Hormone Proteins 0.000 description 1
- 240000004371 Panax ginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 102000007066 Prostate-Specific Antigen Human genes 0.000 description 1
- 108010072866 Prostate-Specific Antigen Proteins 0.000 description 1
- 208000004403 Prostatic Hyperplasia Diseases 0.000 description 1
- 244000088415 Raphanus sativus Species 0.000 description 1
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 description 1
- 240000001949 Taraxacum officinale Species 0.000 description 1
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000001548 androgenic effect Effects 0.000 description 1
- 230000002280 anti-androgenic effect Effects 0.000 description 1
- 239000000051 antiandrogen Substances 0.000 description 1
- 235000009697 arginine Nutrition 0.000 description 1
- 230000037147 athletic performance Effects 0.000 description 1
- 229940002008 bifidobacterium bifidum Drugs 0.000 description 1
- 229940004120 bifidobacterium infantis Drugs 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 235000010216 calcium carbonate Nutrition 0.000 description 1
- 239000013065 commercial product Substances 0.000 description 1
- 235000008504 concentrate Nutrition 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 229940032049 enterococcus faecalis Drugs 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- -1 flavoring Substances 0.000 description 1
- 239000004088 foaming agent Substances 0.000 description 1
- 229940028334 follicle stimulating hormone Drugs 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 239000003163 gonadal steroid hormone Substances 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229940039695 lactobacillus acidophilus Drugs 0.000 description 1
- 229940004208 lactobacillus bulgaricus Drugs 0.000 description 1
- 229940017800 lactobacillus casei Drugs 0.000 description 1
- 229940012969 lactobacillus fermentum Drugs 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 229940040129 luteinizing hormone Drugs 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000006993 memory improvement Effects 0.000 description 1
- 230000005184 men's health Effects 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 229960003966 nicotinamide Drugs 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 229940092385 radish extract Drugs 0.000 description 1
- 238000005549 size reduction Methods 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000002381 testicular Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 235000014692 zinc oxide Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/10—Products from fruits or vegetables; Preparation or treatment thereof of tuberous or like starch containing root crops
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/14—Extraction
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
본 발명은 발효 홍삼, 마카, 쏘팔메토를 주원료로 한 성인 남성용 건강보충용 식품 및 그 제조방법에 관한 것이다. 본 발명의 발효홍삼, 마카, 쏘팔메토가 함유된 성인 남성용 건강보충용 식품은 발효홍삼, 마카, 쏘팔메토를 포함하고 있어 면역력 증진, 피로개선, 혈소판 응집억제를 통한 혈액흐름, 기억력 개선, 항산화 기능, 운동수행능력 향상, 정자운동성 개선 및 갱년기 남성 건강에 도움을 줄 수 있고 전립선 건강에 대한 효과를 가지고 있는 기호성이 뛰어난 성인 남성용 건강기능식품 및 그 제조방법 및 이에 의해 제조된 성인 건강기능성 식품에 관한 것이다.The present invention relates to a health supplement food for adult men using fermented red ginseng, maca, and saw palmetto as main raw materials, and a method for manufacturing the same. The health supplement food for adult men containing fermented red ginseng, maca, and saw palmetto of the present invention contains fermented red ginseng, maca and saw palmetto to enhance immunity, improve fatigue, inhibit platelet aggregation and blood flow, improve memory, and antioxidant Function, exercise performance improvement, sperm motility improvement, menopausal male health, and has an effect on prostate health, excellent palatability for adult men's health functional food, its manufacturing method, and adult health functional food manufactured by it it's about
성인 남성용 건강기능식품은 발효홍삼, 마카, 쏘팔메토가 함유된 성인 남성용 건강보충용 식품은 발효홍삼, 마카, 쏘팔메토를 포함하고 있어 면역력 증진*?*피로개선*?*혈소판 응집억제를 통한 혈액흐름*?*기억력 개선*?*항산화 기능, 운동수행능력 향상, 정자운동성 개선 및 갱년기 남성 건강에 도움을 줄 수 있다. Health functional food for adult men contains fermented red ginseng, maca, and saw palmetto. The health supplement for adult men contains fermented red ginseng, maca, and saw palmetto to enhance immunity*?*improves fatigue*?* through inhibition of platelet aggregation. It can help improve blood flow*?*memory*?* antioxidant function, improve exercise performance, improve sperm motility, and improve menopausal health.
최근 성인 남성용 식품은 남성 생식 기능개선 제품에 집중되어있다 . 예컨데, 국내특허 제 10-1612501호에서는 속새, 산약, 토사자 및 선모 추출물을 유효성분으로 포함하는 남성의 생식기능 개선용 조성물은 속새, 산약, 토사자 및 선모 혼합 추출물은 정액 내 정자 농도를 증가시키고, 정자 활력을 증가시키며, 테스토스테론, 황체형성호르몬 또는 난포자극호르몬과 같은 성호르몬의 분비를 증가시킴으로써 남성의 생식기능을 개선하는데 뛰어난 효과를 나타낸다고 한다. 본 발명은 천연물을 소재로 이용함으로써 저렴한 생산비용과 사용의 편이성을 제공하고 있다. 국내특허 제10-1735242호에서는 무순 추출물을 포함하는 남성 생식기 관련 질환의 예방 또는 치료를 위한 조성물을 제공한다. 본 발명의 무순 추출물은 테스테로스테론 감소 억제, 고환 크기 감소 억제, 정자 감소 억제, 항안드로겐 작용 및 전립선 특이항원 억제 효과 등을 통해서 남성 생식기 관련 질환의 개선, 예방 및 치료에 현저한 효과를 가진다고 개시하고 있다. Recently, food for adult men has been focused on products that improve male reproductive function. For example, in Korean Patent No. 10-1612501, the composition for improving male reproductive function, which contains extracts of Sossaea, Sanyak, Tosaja, and Semen as active ingredients, increases the concentration of sperm in semen, It increases sperm vitality and increases the secretion of sex hormones such as testosterone, luteinizing hormone or follicle-stimulating hormone, which is said to have an excellent effect on improving male reproductive function. The present invention provides low production cost and ease of use by using a natural product as a material. Korean Patent No. 10-1735242 provides a composition for the prevention or treatment of male genital-related diseases, which includes an extract of radish sprouts. The radish extract of the present invention discloses that it has a remarkable effect in the improvement, prevention and treatment of male genital-related diseases through inhibition of testosterone reduction, inhibition of testicular size reduction, inhibition of sperm reduction, anti-androgen action and prostate-specific antigen inhibitory effect. have.
그러나, 국내특허 제 10-1621072호는 캐롭 및 꾸지뽕의 복합추출물을 유효성분으로 포함하는 남성 갱년기 증상의 예방 또는 개선용 조성물을 제공한다. 본 발명의 조성물은 남성 갱년기 증상의 원인인 테스토스테론의 감소를 완화하고 운동능력을 향상시키며, 5-α 리덕타아제의 활성을 억제하여 전립선 비대증에 대하여 예방 및 치료 효과를 나타내어 다양한 남성 갱년기 증상을 개선하는데 유효하다. 본 발명은 캐롭 및 꾸지뽕의 복합추출물을 유효성분으로 포함하는 남성 생식기능 개선용 조성물을 제공한다. 본 발명의 조성물은 정액 내 정자 농도를 증가시키고, 정자 운동성을 증가시키며, 테스토스테론의 분비를 증가시킴으로써 남성의 생식기능을 개선하는 데 뛰어난 효과를 나타낸다. 본 발명의 캐롭 및 꾸지뽕의 복합추출물은 캐롭 및 꾸지뽕 단일 추출물과 비교하여 현저히 증가된 남성 갱년기 증상 개선 효과 및 남성 생식기능 개선 효과를 나타내며 낸다. 본 발명의 면역력 증진*?*피로개선*?*혈소판 응집억제를 통한 혈액흐름*?*기억력 개선*?*항산화 기능, 운동수행능력 향상, 정자운동성 개선 및 갱년기 남성 건강에 도움을 줄 수 있는 그 목적과 구성을 달리한다. However, Korean Patent No. 10-1621072 provides a composition for preventing or improving male menopausal symptoms comprising a complex extract of kaerop and kkujippong as an active ingredient. The composition of the present invention alleviates a decrease in testosterone, which is the cause of andropause symptoms, improves athletic performance, and inhibits the activity of 5-α reductase to exhibit preventive and therapeutic effects on prostatic hyperplasia, thereby improving various androgenic symptoms it is valid to The present invention provides a composition for improving male reproductive function comprising a complex extract of kaerop and kkujippong as an active ingredient. The composition of the present invention exhibits excellent effects in improving male reproductive function by increasing sperm concentration in semen, increasing sperm motility, and increasing testosterone secretion. The complex extract of kaerop and cujippong of the present invention exhibits significantly increased male menopause symptom improvement effect and male reproductive function improvement effect compared to kaerop and cujippong single extract. Improving immunity of the present invention*?*improving fatigue*?*blood flow through inhibition of platelet aggregation*?*improving memory*?*Antioxidant function, improving exercise performance, improving sperm motility and menopausal male health different purpose and composition.
본 발명에 이용되는 발효홍삼은 홍삼을 발효하여 사용하여 생체내 흡수를 좋게 하였으며 이와 더불어 마카, 쏘팔메토를 포함하여 성인 남성을 위한 건강기능식품으로 부원료를 첨가하여 섭취하기 용이하도록 제조하였다. Fermented red ginseng used in the present invention was fermented and used to improve absorption in vivo. In addition, it was prepared to be easily consumed by adding auxiliary ingredients as health functional foods for adult men, including maca and saw palmetto.
종래의 남성 성인용 건강기능식품은 남성 생식 기능 개선에 중점적으로 집중하여 많이 만들어진 제품이 많은 실정이다. Conventional health functional food for men for adults is a situation in which many products are made by focusing on the improvement of male reproductive function.
그런데 40~50대의 나이에 진입하는 성인의 경우에는 개인에 따라서 갱년기 증상은 차이가 있으나 모든 남성은 노화의 과정을 겪으며 이와 동시에 인체의 기능이 떨어집니다. 사실상 갱년기는 호르몬의 감소가 주된 원인이라고 할 수 있는데, 남성에서의 호르몬 생산은 30세를 정점으로 해마다 1%씩 감소합니다. 이 때문에 갱년기 증상이 나타나게 됩니다. 민들레와 루이보스의 복합 추출물로, 남성호르몬과 남성 갱년기 현상 개선, 은행잎 추출물은 혈행과 기억력 개선에 도움을 줄 수 있고 옥타코사놀은 지구력 강화에 효과가 있는 것으로 알려진 제품이 나오고 있다. However, in the case of adults entering the age of 40-50, the symptoms of menopause vary depending on the individual, but all men go through the process of aging and at the same time, the function of the human body decreases. In fact, it can be said that the main cause of menopause is a decrease in hormones, and the production of hormones in men decreases by 1% per year after peaking at the age of 30. This causes menopausal symptoms to appear. It is a complex extract of dandelion and rooibos. Testosterone and male menopause improvement, ginkgo leaf extract can help improve blood circulation and memory, and octacosanol is known to be effective in strengthening endurance.
본발명은 기존의 성인 남성용 건강기능식품의 문제점을 해결하고자 연구되었는데 특히, 발효홍삼이 오랜 시간 동안 섭취하여 안전성이 있는 마카, 쏘팔메토를 혼합하여 복합 기능성 성인 남성용 건강기능 식품을 장기간에 걸쳐 연구하였다. The present invention has been studied to solve the problems of the existing health functional food for adult men. In particular, it is a long-term study of a complex functional health functional food for adult men by mixing maca and saw palmetto, which are safe because fermented red ginseng is consumed for a long time. did.
본발명자들은 발효홍삼을 이용하고 마카, 쏘팔메토에 섭취하기 좋게 기호성을 향상시키고 기존의 갱년기 남성용 제품과 다른 독특한 향과 맛을 내도록 하고, 거부감을 느끼지 않게 하였으며, 이를 위해 발효홍삼, 마카, 쏘팔메토의 최적화된 비율을 제공하고자 한다. The present inventors used fermented red ginseng, improved palatability to be consumed in maca and saw palmetto, gave a unique flavor and taste different from existing menopausal products, and did not feel objectionable. For this purpose, fermented red ginseng, maca, saw We want to provide an optimized proportion of palmetto.
또한, 본 발명은 발효홍삼과 마카, 쏘팔메토를 사용함에도 불구하고, 부원료를 적절히 사용하여 부드러운 맛과 향을 내도록 한 성인 남성용 건강기능식품 및 그 제조방법을 제공하고자 한다. In addition, the present invention is to provide a health functional food for adult men and a method for producing the same, in which, despite the use of fermented red ginseng, maca, and saw palmetto, supplementary materials are appropriately used to give a soft taste and fragrance.
상기와 같은 과제를 수행하기 위하여, 본 발명은 홍삼액에 유산균을 접종하는 단계; 상기의 유산균 및 효소의 혼합물로 접종된 홍삼액을 발효시키는 단계; 및 상기의 발효가 완료된 후 홍삼액을 여과하고 홍삼액 내의 진세노사이드의 함량이 높은 홍삼액을 제조하여 이를 농축하여 발효홍삼액을 제조하는 단계와 이를 활용한 발효홍삼 농축액분말, 마카, 쏘팔메토, 구연산, 감미료, 무기질, 비타민, 향료를 혼합하는 단계와; 상기 혼합물을 과립하는 단계로 이루어진 성인 남성용 건강기능식품 제조방법을 제공하고자 한다.In order to perform the above tasks, the present invention comprises the steps of inoculating lactic acid bacteria in red ginseng solution; fermenting the red ginseng solution inoculated with the mixture of lactic acid bacteria and enzymes; And after the fermentation is completed, filtering the red ginseng solution, preparing a red ginseng solution with a high ginsenoside content in the red ginseng solution, and concentrating it to prepare a fermented red ginseng solution, and using the same, fermented red ginseng concentrate powder, maca, saw palmetto, citric acid, mixing sweeteners, minerals, vitamins, and flavorings; An object of the present invention is to provide a method for manufacturing a health functional food for adult men comprising the step of granulating the mixture.
본 발명에 의해 제조한 발효 홍삼, 마카, 쏘팔메토를 주원료는 면역력 증진*?*피로개선*?*혈소판 응집억제를 통한 혈액흐름*?*기억력 개선*?*항산화 기능, 운동수행능력 향상, 정자운동성 개선 및 갱년기 남성 건강에 도움을 줄 수 있고 전립선 건강에 대한 효과를 가지고 있는 기호성이 뛰어난 과립형 성인 남성용 건강기능식품을 제공 할 수 있다.Fermented red ginseng, maca, and saw palmetto produced by the present invention as main raw materials enhance immunity*?*improves fatigue*?*blood flow through inhibition of platelet aggregation*?*improves memory*?*antioxidant function, improves exercise performance, It is possible to provide a granular health functional food for adult men with excellent palatability, which can help improve sperm motility and menopausal health, and have an effect on prostate health.
이하, 본 발명을 상세하게 설명한다.Hereinafter, the present invention will be described in detail.
본 발명의 발효홍삼, 마카, 쏘팔메토가 함유된 성인 남성용 건강보충용 식품은 발효홍삼, 마카, 쏘팔메토를 포함하고 있어 면역력 증진*?*피로개선*?*혈소판 응집억제를 통한 혈액흐름*?*기억력 개선*?*항산화 기능, 운동수행능력 향상, 정자운동성 개선 및 갱년기 남성 건강에 도움을 줄 수 있고 전립선 건강에 대한 효과를 가지고 있는 기호성이 뛰어난 성인 남성용 건강기능식품 제조방법에 관한 것이다.The dietary supplement for adult men containing fermented red ginseng, maca and saw palmetto of the present invention contains fermented red ginseng, maca and saw palmetto to enhance immunity*?*improves fatigue*?*blood flow through inhibition of platelet aggregation* ?*Improvement of memory*?*Antioxidant function, improvement of exercise performance, improvement of sperm motility and menopausal health It relates to a manufacturing method of a health functional food for adult men with excellent palatability and effect on prostate health.
본 발명은 홍삼액에 유산균을 접종하는 단계; 상기의 유산균 및 효소의 혼합물로 접종된 홍삼액을 발효시키는 단계; 및 상기의 발효가 완료된 후 홍삼액을 여과하고 홍삼액 내의 진세노사이드의 함량이 높은 홍삼액을 제조하여 이를 농축하여 발효홍삼액을 제조하는 단계와 이를 활용한 발효홍삼 농축액분말, 마카, 쏘팔메토, 구연산, 감미료, 무기질, 비타민, 향료를 혼합하는 단계와; 상기 혼합물을 과립하는 단계로 이루어진 성인 남성용 건강기능식품 제조방법을 나타낸다. The present invention comprises the steps of inoculating lactic acid bacteria in red ginseng solution; fermenting the red ginseng solution inoculated with the mixture of lactic acid bacteria and enzymes; And after the fermentation is completed, filtering the red ginseng solution, preparing a red ginseng solution with a high ginsenoside content in the red ginseng solution, and concentrating it to prepare a fermented red ginseng solution, and using the same, fermented red ginseng concentrate powder, maca, saw palmetto, citric acid, mixing sweeteners, minerals, vitamins, and flavorings; It shows a method for manufacturing a health functional food for adult men comprising the step of granulating the mixture.
상기에서 홍삼액은 홍삼을 착즙하여 얻은 홍삼착즙액을 농도가 2~20brix가 되도록 조절한 홍삼액을 사용할 수 있다.As the red ginseng liquid, red ginseng liquid obtained by squeezing red ginseng may be used in a concentration of 2 to 20 brix.
상기에서 홍삼액은 홍삼을 열수로 추출하여 얻은 홍삼추출액을 농도가 2~20brix가 되도록 조절한 홍삼액을 사용할 수 있다.As the red ginseng solution, a red ginseng solution obtained by extracting red ginseng with hot water may be used in a concentration of 2 to 20 brix.
상기의 홍삼액의 일예로서 홍삼을 홍삼 중량 대비 8~20배량의 정제수에 첨가하고 90~120℃에서 최초 정제수의 부피 대비 5~50%가 되도록 추출한 후 여과수단에 의해 여과하여 얻은 홍삼추출액을 농도가 2~20brix가 되도록 조절한 홍삼액을 사용할 수 있다.As an example of the red ginseng solution, red ginseng is added to purified water in an amount of 8 to 20 times the weight of red ginseng, extracted to be 5 to 50% of the volume of the first purified water at 90 to 120 ° C. Red ginseng solution adjusted to 2-20 brix can be used.
상기의 홍삼액의 일예로서 홍삼을 홍삼 중량 대비 8~20배량의 정제수에 첨가하고 90~120℃에서 최초 정제수의 부피 대비 5~40%가 되도록 추출한 후 여과수단에 의해 여과하여 얻은 홍삼추출액을 농도가 2~20brix가 되도록 조절한 홍삼액을 사용할 수 있다.As an example of the above red ginseng solution, red ginseng is added to purified water in an amount of 8 to 20 times the weight of red ginseng, extracted to be 5 to 40% of the volume of the first purified water at 90 to 120 ° C. Red ginseng solution adjusted to 2-20 brix can be used.
상기의 홍삼액의 일예로서 홍삼을 홍삼 중량 대비 8~20배량의 정제수에 첨가하고 90~120℃에서 최초 정제수의 부피 대비 5~30%가 되도록 추출한 후 여과수단에 의해 여과하여 얻은 홍삼추출액을 농도가 2~20brix가 되도록 조절한 홍삼액을 사용할 수 있다.As an example of the red ginseng solution, red ginseng is added to purified water in an amount of 8 to 20 times the weight of red ginseng, extracted to be 5 to 30% of the volume of the first purified water at 90 to 120 ° C. Red ginseng solution adjusted to 2-20 brix can be used.
상기의 홍삼액의 일예로서 홍삼을 홍삼 중량 대비 8~20배량의 정제수에 첨가하고 90~120℃에서 최초 정제수의 부피 대비 5~20%가 되도록 추출한 후 여과수단에 의해 여과하여 얻은 홍삼추출액을 농도가 2~20brix가 되도록 조절한 홍삼액을 사용할 수 있다.As an example of the red ginseng solution, red ginseng is added to purified water in an amount of 8 to 20 times the weight of red ginseng, extracted to be 5 to 20% of the volume of the first purified water at 90 to 120 ° C. Red ginseng solution adjusted to 2-20 brix can be used.
상기의 홍삼액을 얻기 위한 재료인 홍삼은 시중에서 상품으로 판매되고 있는 것을 사용할 수 있다.Red ginseng, which is a material for obtaining the red ginseng liquid, may be used as a commercial product.
상기의 홍삼액을 얻기 위한 재료인 홍삼은 인삼을 80~100℃의 수증기(steam)로 3~6시간 동안 증숙하고 상온의 공기중에서 20~25℃로 냉각하는 증숙 및 냉각공정을 1~9회 실시하여 얻은 홍삼을 사용할 수 있다.For red ginseng, the material for obtaining the above red ginseng liquid, steaming ginseng with steam at 80-100℃ for 3-6 hours and cooling it to 20-25℃ in air at room temperature is performed 1-9 times. The obtained red ginseng can be used.
상기에서 홍삼액은 진세노사이드 Rb1 및 진세노사이드 Rg1을 합한 함량이 3~40mg 함유된 것을 사용할 수 있다.In the above red ginseng solution, 3 to 40 mg of ginsenoside Rb1 and ginsenoside Rg1 may be used.
상기에서 홍삼액은 농도가 2~650brix이며 진세노사이드 Rb1 및 진세노사이드 Rg1을 합한 함량이 3~40mg 함유된 것을 사용할 수 있다.In the above, the red ginseng solution may have a concentration of 2 to 650 brix and a content containing 3 to 40 mg of ginsenoside Rb1 and ginsenoside Rg1 may be used.
상기에서 홍삼액은 농도가 2~65brix이며 진세노사이드 Rb1, 진세노사이드 Rg1 및 진세노사이드 Rg3을 합한 함량이 3~40mg 함유된 것을 사용할 수 있다.In the above, the red ginseng solution has a concentration of 2∼65brix and contains 3∼40 mg of ginsenoside Rb1, ginsenoside Rg1 and ginsenoside Rg3.
상기에서 홍삼액은 농도가 2~65brix이며 진세노사이드 Rb1, 진세노사이드 Rg1 및 진세노사이드 Rg3을 합한 함량이 3mg 함유된 것을 사용할 수 있다.In the above, the red ginseng solution may have a concentration of 2 to 65brix and contain 3 mg of ginsenoside Rb1, ginsenoside Rg1, and ginsenoside Rg3.
상기에서 홍삼액은 농도가 2~65brix이며 진세노사이드 Rb1, 진세노사이드 Rg1 및 진세노사이드 Rg3을 합한 함량이 10mg 함유된 것을 사용할 수 있다.In the above, the red ginseng solution may have a concentration of 2 to 65brix and contain 10 mg of ginsenoside Rb1, ginsenoside Rg1, and ginsenoside Rg3.
상기에서 홍삼액은 농도가 2~65brix이며 진세노사이드 Rb1, 진세노사이드 Rg1 및 진세노사이드 Rg3을 합한 함량이 20mg 함유된 것을 사용할 수 있다.In the above, the red ginseng liquid has a concentration of 2 to 65 brix, and 20 mg of ginsenoside Rb1, ginsenoside Rg1, and ginsenoside Rg3 may be used.
상기에서 홍삼액은 농도가 2~65brix이며 진세노사이드 Rb1, 진세노사이드 Rg1 및 진세노사이드 Rg3을 합한 함량이 30mg 함유된 것을 사용할 수 있다.In the above, the red ginseng liquid has a concentration of 2 to 65 brix and 30 mg of ginsenoside Rb1, ginsenoside Rg1 and ginsenoside Rg3 may be used.
상기에서 홍삼액은 농도가 2~65brix이며 진세노사이드 Rb1, 진세노사이드 Rg1 및 진세노사이드 Rg3을 합한 함량이 40mg 함유된 것을 사용할 수 있다.In the above, the red ginseng liquid has a concentration of 2 to 65 brix and 40 mg of ginsenoside Rb1, ginsenoside Rg1, and ginsenoside Rg3 may be used.
상기에서 유산균은 락토바실러스(Lactobacillus), 류코노스톡(Leuconostoc), 엔테로코커스(Enterococcus), 비피도박테리움(Bifidobacterium) 및 스트렙토코커스(Streptococcus) 중에서 선택된 어느 하나 이상의 유산균을 사용할 수 있다. In the lactic acid bacteria can use the Lactobacillus bacteria (Lactobacillus), flow Pocono stock (Leuconostoc), Enterococcus (Enterococcus), Bifidobacterium (Bifidobacterium) and any one or more lactic acid bacteria selected from Streptococcus (Streptococcus).
상기에서 유산균은 락토바실러스 플란타럼(Lactobacillus plantarum), 락토바실러스 알리멘타리우스(Lactobacillus alimentarius), 락토바실러스 사케이(Lactobacillus sakei), 락토바실러스 아시도필러스(Lactobacillus acidophilus), 락토바실러스 카세이(Lactobacillus casei), 락토바실러스 가세리(Lactobacillus gasseri), 락토바실러스 델브루엑키(Lactobacillus delbrueckii), 락토바실러스 퍼멘텀(Lactobacillus fermentum), 락토바실러스 불가리쿠스(Lactobacillus bulgaricus), 락토바실러스 헬베티쿠스(Lactobacillus helveticus), 류코노스톡 멘센테로이드스(Leuconostoc mensenteroides), 엔테로코커스 파에시엄(Enterococcus faecium), 엔테로코커스 파에칼리스(Enterococcus faecalis), 비피도박테리엄 비피덤(Bifidobacterium bifidum), 비피도박테리엄 인판티스(Bifidobacterium infantis), 비피도박테리엄 브라베(Bifidobacterium brave), 비피도박테리엄 롱검(Bifidobacterium longum), 스트렙토코커스 서모필러스(Streptococcus thermophilus) 및 스트렙토코커스 락티스(Streptococcus lactis) 중에서 선택된 어느 하나 이상의 유산균을 사용할 수 있다. Said in lactic acid bacteria is Lactobacillus Planta Rum (Lactobacillus plantarum), Lactobacillus Ali menta Aquarius (Lactobacillus alimentarius), Lactobacillus four K (Lactobacillus sakei), Lactobacillus know also the filler's (Lactobacillus acidophilus), Lactobacillus Kasei (Lactobacillus casei ), Lactobacillus biasing Li (Lactobacillus gasseri), Lactobacillus del Brewer ekki (Lactobacillus delbrueckii), Lactobacillus buffer momentum (Lactobacillus fermentum), Lactobacillus Bulgaria kusu (Lactobacillus bulgaricus), Lactobacillus helveticus (Lactobacillus helveticus), flow Leuconostoc mensenteroides , Enterococcus faecium , Enterococcus faecalis , Bifidobacterium bifidum infantis, Bifidobacterium infantis , Bifidobacterium brave ( Bifidobacterium brave ), Bifidobacterium longum ( Bifidobacterium longum ), Streptococcus thermophilus ( Streptococcus thermophilus ) and Streptococcus lactis ( Streptococcus lactis ) Any one or more lactic acid bacteria selected from can be used .
상기에서 유산균이 접종된 홍삼액은 35~45℃에서 2~12일 동안 10~50rpm으로 교반하여 발효시킬 수 있다.The red ginseng solution inoculated with lactic acid bacteria in the above can be fermented by stirring at 10-50 rpm for 2-12 days at 35-45 ℃.
상기에서 상기의 발효가 완료된 후 홍삼액을 여과수단에 의해 여과하고 여과된 홍삼액을 80~130℃에서 10~120분 처리하여 홍삼액 내의 유산균을 불활성화시킬 수 있다.In the above, after the fermentation is completed, the red ginseng solution is filtered by a filtration means, and the filtered red ginseng solution is treated at 80 to 130° C. for 10 to 120 minutes to inactivate lactic acid bacteria in the red ginseng solution.
상기에서 여과수단은 종래 용액을 여과할 수 있는 수단, 일예로 여과지, 여과포, 여과막, 여과장치 중에서 선택된 어느 하나 이상의 여과수단을 이용할 수 있다. 이러한 여과수단은 당업자가 적의 선택하여 실시할 수 있으면 족하므로 이에 대한 자세한 내용은 생략하기로 한다.In the above, the filtration means may use any one or more filtration means selected from conventional means for filtering a solution, for example, filter paper, filter cloth, filtration membrane, and a filtration device. These filtering means are sufficient as long as those skilled in the art can appropriately select and implement them, so the detailed description thereof will be omitted.
상기에서 홍삼액 내의 유산균 불활성화는 보통의 살균하는 온도에 준하는 고온에서 실시하므로 별도의 살균공정을 실시하지 않아도 좋다.In the above, the lactic acid bacteria inactivation in the red ginseng solution is carried out at a high temperature equivalent to the normal sterilization temperature, so there is no need to perform a separate sterilization process.
상기에서 발효홍삼 농축액, 탄산수소나트륨, 구연산, 감미료, 무기질, 비타민, 향료를 혼합하는 단계와 상기 발포제가 혼합물을 타정기로 사용하여 제조 할 수 있다.The step of mixing the fermented red ginseng concentrate, sodium hydrogen carbonate, citric acid, sweetener, minerals, vitamins, and flavoring in the above and the foaming agent can be prepared by using the mixture in a tableting machine.
본 발명의 발효홍삼 농축액 분말을 함유하는 발효홍삼 분말, 마카, 쏘팔메토 혼합 제품 제조방법에 대해 다양한 조건으로 실시한바, 본 발명의 목적을 달성하기 위해서는 상기에서 언급한 조건에 의해 성인 남성용 건강기능식품의 제조방법을 제공하는 것이 바람직하다.The method for producing a mixed product of fermented red ginseng powder, maca, and saw palmetto containing the fermented red ginseng concentrate powder of the present invention was carried out under various conditions. It is desirable to provide a method for manufacturing a food product.
이하 본 발명의 내용을 실시예를 통하여 구체적으로 설명한다. 그러나, 이들은 본 발명을 보다 상세하게 설명하기 위한 것으로 본 발명의 권리범위가 이들에 의해 한정되는 것은 아니다.Hereinafter, the contents of the present invention will be described in detail through examples. However, these are for describing the present invention in more detail, and the scope of the present invention is not limited thereto.
[실시예1][Example 1]
아래와 같이 발효 홍삼분말, 마카, 쏘팔메토를 함유하는 과립제품을 제조 하였다.A granular product containing fermented red ginseng powder, maca, and saw palmetto was prepared as follows.
상기 투입한 홍삼농축액을 희석한 후 유산균배양액을 투입하여 배양탱크 온도 37℃ 유지하면서 12일간 발효한다. After diluting the added red ginseng concentrate, the lactic acid bacteria culture solution is added and the culture tank temperature is maintained at 37° C. and fermented for 12 days.
상기 유산균배양액은 MRS 배지에 유산균배양액 (멸균수 90%, 홍삼농축액 10%에 유산균 (Lactobacillus와 Leuconostoc 복합 유산균)1 X 108 cfu/g 이상 배양된 액)을 접종하고 37℃에서 7일간 배양하여 유산균수가 1X109 cfu/g 이상이 되도록 배양한 액을 말한다.The lactic acid bacteria culture medium was inoculated with lactic acid bacteria culture medium (sterilized water 90%, red ginseng concentrate 10% lactic acid bacteria (Lactobacillus and Leuconostoc complex lactic acid bacteria) 1 X 10 8 cfu / g or more) and cultured at 37 ° C for 7 days. It refers to a solution cultured so that the number of lactic acid bacteria is 1X10 9 cfu/g or more.
상기 발효를 마친 홍삼발효액을 95℃로 2시간 살균한다. The fermented red ginseng solution after the fermentation is sterilized at 95° C. for 2 hours.
상기 홍삼발효액을 진공감압농축(가압 600-700mmHg) 온도 60℃ 이하에서 고형분 60%이상, 물불용성침전물 3% 이하로 농축한다.The red ginseng fermented liquid is concentrated under vacuum pressure (pressure 600-700 mmHg) at a temperature of 60° C. or less to have a solid content of 60% or more and a water-insoluble precipitate of 3% or less.
상기 농축한 발효 홍삼액을 동결건조하여 분말로 만들고 발효홍삼, 마카, 쏘팔메토, 말티톨, 니코틴산아미드,판토텐산칼슘,산화아연,탄산칼슘,슈크랄로스,아세설팜K, 스테비아,복분자추출분말,아르기닌,덱스트린,비타민 C,향료,변성전분를 혼합하여 20mesh 을 설치한 오실레이터에 넣어 과립제품을 제조한다. The concentrated fermented red ginseng solution is freeze-dried to make powder, and fermented red ginseng, maca, saw palmetto, maltitol, nicotinic acid amide, calcium pantothenate, zinc oxide, calcium carbonate, sucralose, acesulfame K, stevia, bokbunja extract powder, Arginine, dextrin, vitamin C, flavoring, and modified starch are mixed and put in an oscillator equipped with 20 mesh to manufacture granulated products.
[실시예2][Example 2]
상술한 바와 같이, 본 발명의 바람직한 실시예를 참조하여 설명하였지만 해당 기술 분야의 숙련된 당업자라면 하기의 특허청구범위에 기재된 본 발명의 사상 및 영역으로부터 벗어나지 않는 범위 내에서 본 발명을 다양하게 수정 및 변경시킬 수 있음을 이해할 수 있을 것이다. As described above, although described with reference to preferred embodiments of the present invention, those skilled in the art can variously modify and modify the present invention within the scope without departing from the spirit and scope of the present invention as set forth in the following claims. You will understand that it can be changed.
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020200042781A KR20210125273A (en) | 2020-04-08 | 2020-04-08 | Health functional food for adult men and Manufacturing method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020200042781A KR20210125273A (en) | 2020-04-08 | 2020-04-08 | Health functional food for adult men and Manufacturing method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20210125273A true KR20210125273A (en) | 2021-10-18 |
Family
ID=78271494
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020200042781A KR20210125273A (en) | 2020-04-08 | 2020-04-08 | Health functional food for adult men and Manufacturing method thereof |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20210125273A (en) |
-
2020
- 2020-04-08 KR KR1020200042781A patent/KR20210125273A/en not_active Application Discontinuation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104489669A (en) | Plant enzyme probiotic powder and preparation method thereof | |
US9596875B2 (en) | Fermented food containing Bifidobacterium bacteria and method for producing the same | |
CN102669762B (en) | Banana beverage and preparation method thereof | |
CN102028133A (en) | Fermented tomato sauce and preparation method thereof | |
CN102090482A (en) | Fermented tea beverage and preparation method thereof | |
JP5750785B2 (en) | Lactic acid bacteria growth promoter | |
CN102871183A (en) | Black fungus beverage and preparation method thereof | |
CN102090617B (en) | Tea sauce and preparation method thereof | |
CN105285285A (en) | Blueberry pressed candy and preparation method thereof | |
CN105285286A (en) | Blueberry pressed candy with high contents of viable probiotics and preparation method thereof | |
CN105076648A (en) | Blueberry tablet candy with beautifying and antibacterial efficacy and preparation method thereof | |
CN102028134A (en) | Fermented carrot sauce and preparation method thereof | |
CN106174500A (en) | A kind of manufacture method of Fructus Jujubae composite enzyme | |
CN104605018B (en) | A kind of feature acidified milk and preparation method thereof | |
CN112314704A (en) | Preparation method of low-sensitization flavored yogurt product | |
CN106107378A (en) | A kind of enzyme beverage with Folium Nelumbinis as main material and preparation method thereof | |
CN109349480A (en) | A kind of fermentative tuckahoe beverage and preparation method thereof | |
CN105076649A (en) | Blueberry pressed candies capable of delaying ageing and preparation method of blueberry pressed candies | |
CN111248384A (en) | Composite probiotic enzyme beverage and preparation method thereof | |
KR101605085B1 (en) | Fermented pills comprising artemisia annua and method for preparing the same | |
CN109430476A (en) | Tea ferment drink and preparation method thereof with defaecation ease constipation function | |
KR20210125273A (en) | Health functional food for adult men and Manufacturing method thereof | |
KR101908647B1 (en) | Preparation of probiotic lactic acid bacteria using herbal-medicines extracts | |
CN110810807A (en) | Fermented tomato sauce and preparation method thereof | |
CN113331331A (en) | Preparation method of probiotic fermented beverage |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E902 | Notification of reason for refusal | ||
E601 | Decision to refuse application |